The association of anticoagulation before admission and survival of patients with COVID-19.

Kuno, Toshiki; Takahashi, Mai; So, Matsuo; Egorova, Natalia N

Kuno, Toshiki; Takahashi, Mai; So, Matsuo; Egorova, Natalia N.

Afiliação

Kuno T; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA; Department of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, NY, USA. Electronic address: tkuno@montefiore.org.
Takahashi M; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA.
So M; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA.
Egorova NN; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, NY, USA.

J Cardiol ; 79(4): 489-493, 2022 04.

Article em En | MEDLINE | ID: mdl-34974942

Assuntos

Fibrilação Atrial; COVID-19; Anticoagulantes/uso terapêutico; Fibrilação Atrial/complicações; Fibrilação Atrial/tratamento farmacológico; Humanos; Estudos Retrospectivos; SARS-CoV-2

Palavras-chave

Anticoagulation before admission; Coronavirus disease 2019; In-hospital mortality

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google